Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Tollefson

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Biological Psychiatry|February 13, 2001
No gender differences in placebo responses of patients with major depressive disorderR C Casper, G D Tollefson, M E Nilsson
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1991
The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home populationG D Tollefson, J Montague-Clouse, S P Lancaster
The American Journal of Psychiatry|August 1, 1984
Migraine headaches and depressionM J Garvey, G D Tollefson, C B Schaffer
Depression and Anxiety|June 6, 1998
Health economic evaluations of antidepressants: a reviewT R Hylan, D P Buesching, G D Tollefson
The Journal of Clinical Psychiatry|January 1, 1997
Safety of olanzapineC M Beasley, G D Tollefson, P V Tran
Comprehensive Psychiatry|September 1, 1986
Is chronic primary major depression a distinct depression subtype?M J Garvey, G D Tollefson, V B Tuason
Psychiatry Research|March 1, 1987
Elevations of urinary MHPG in depressed patients with panic attacksM J Garvey, G D Tollefson, P J Orsulak
Schizophrenia Research|July 25, 1997
The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsA M Crawford, C M Beasley, G D Tollefson
Journal of Psychiatric Research|January 1, 1982
Ionic regulation of antagonist binding to the human muscarinic cholinergic receptor of caudate nucleusG D Tollefson, S E Senogles, W H Frey
The Journal of Clinical Psychiatry|January 1, 1997
Efficacy of olanzapine: an overview of pivotal clinical trialsC M Beasley, G D Tollefson, P V Tran
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Biological Psychiatry|February 13, 2001
No gender differences in placebo responses of patients with major depressive disorderR C Casper, G D Tollefson, M E Nilsson
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1991
The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home populationG D Tollefson, J Montague-Clouse, S P Lancaster
The American Journal of Psychiatry|August 1, 1984
Migraine headaches and depressionM J Garvey, G D Tollefson, C B Schaffer
Depression and Anxiety|June 6, 1998
Health economic evaluations of antidepressants: a reviewT R Hylan, D P Buesching, G D Tollefson
The Journal of Clinical Psychiatry|January 1, 1997
Safety of olanzapineC M Beasley, G D Tollefson, P V Tran
Comprehensive Psychiatry|September 1, 1986
Is chronic primary major depression a distinct depression subtype?M J Garvey, G D Tollefson, V B Tuason
Psychiatry Research|March 1, 1987
Elevations of urinary MHPG in depressed patients with panic attacksM J Garvey, G D Tollefson, P J Orsulak
Schizophrenia Research|July 25, 1997
The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsA M Crawford, C M Beasley, G D Tollefson
Journal of Psychiatric Research|January 1, 1982
Ionic regulation of antagonist binding to the human muscarinic cholinergic receptor of caudate nucleusG D Tollefson, S E Senogles, W H Frey
The Journal of Clinical Psychiatry|January 1, 1997
Efficacy of olanzapine: an overview of pivotal clinical trialsC M Beasley, G D Tollefson, P V Tran
Pageof 11